Evaluation in Nonhuman Primates of Vaccines against Ebola Virus
Ebola virus (EBOV) causes acute hemorrhagic fever that is fatal in up to 90% of cases in both humans and nonhuman primates. No vaccines or treatments are available for human use. We evaluated the effects in nonhuman primates of vaccine strategies that had protected mice or guinea pigs from lethal EB...
Main Authors: | Thomas W. Geisbert, Peter Pushko, Kevin Anderson, Jonathan Smith, Kelly J. Davis, Peter B. Jahrling |
---|---|
Format: | Article |
Language: | English |
Published: |
Centers for Disease Control and Prevention
2002-05-01
|
Series: | Emerging Infectious Diseases |
Subjects: | |
Online Access: | https://wwwnc.cdc.gov/eid/article/8/5/01-0284_article |
Similar Items
-
Développement d'un vecteur virus de la vaccine, réplicatif et atténué, pour la vaccination antivariolique et pour la vaccination contre la fièvre hémorragique à virus Ebola
by: Dimier, Julie
Published: (2012) -
Antiviral Innate Responses Induced by VSV-EBOV Vaccination Contribute to Rapid Protection
by: Andrea R. Menicucci, et al.
Published: (2019-05-01) -
Surveillance for Ebola Virus in Wildlife, Thailand
by: Supaporn Wacharapluesadee, et al.
Published: (2015-12-01) -
Ebola vaccine 2014: remained problems to be answered
by: Somsri Wiwanitkit, et al.
Published: (2015-02-01) -
Pregnancy Outcomes among Women Receiving rVSVΔ-ZEBOV-GP Ebola Vaccine during the Sierra Leone Trial to Introduce a Vaccine against Ebola
by: Jennifer K. Legardy-Williams, et al.
Published: (2020-03-01)